Takeda Pharmaceutical Ratios (2018-2026) | TAK

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Ratios	Mar2018	Mar2019	Mar2020	Mar2021	Mar2022	Mar2023	Mar2024	Mar2025	Dec2025	Mar2026
Profitability
Gross Margin (Quarter)									62.89%
EBT Margin (Quarter)									15.19%
EBIT Margin (Quarter)									18.36%
EBITDA Margin (Quarter)									18.36%
Operating Margin (Quarter)									18.36%
Net Margin (Quarter)									12.85%
Efficiency
Inventory Average (Quarter)		5.16B	7.67B	7.05B	7.23B	7.40B	7.81B	8.07B
Assets Average (Quarter)					440.67B	468.54B	450.76B	268.12B	207.13B	209.70B
Equity Average (Quarter)		32.86B	45.26B	46.17B	48.92B	48.48B	48.56B	47.27B
Invested Capital (Quarter)	27.71B	99.34B	90.20B	92.70B	86.32B	81.17B	81.77B	75.06B		77.44B
Leverage & Solvency
Interest Coverage Ratio (Quarter)									-4.02
Debt to Equity (Quarter)	0.05	0.93	0.97	0.10	0.12	0.69	0.11	1.14		0.56
Debt Ratio (Quarter)	0.02	0.35	0.36	0.04	0.05	0.31	0.06	0.56		0.28
Equity Ratio (Quarter)	0.49	0.38	0.37	0.40	0.43	0.46	0.48	0.49		0.50
Times Interest Earned (Quarter)									-4.02
Valuation
Enterprise Value (Quarter)	-3.46B	-6.59B	-6.00B	-9.47B	-7.53B	-4.19B	-3.19B	-4.83B		-6.60B
Return Ratios
Return on Sales (Quarter)									0.00%
Return on Assets (Quarter)									0.00%	0.00%